Related by context. All words. (Click for frequent words.) 70 STRIDE PD 69 rolofylline 69 rFVIIa 69 Atacand 68 riociguat 68 Desmoteplase 68 Cinquil 68 NV1FGF 68 ruboxistaurin 67 NATRECOR R 67 sitaxsentan 67 invasive candidiasis 67 CIMZIA TM certolizumab pegol 67 ocrelizumab 67 Corlux 67 dexanabinol 67 Canvaxin 67 symptomatic intracranial 67 diabetic neuropathic pain 67 Potiga 67 midstage clinical 67 Kepivance 67 ATACAND 67 terlipressin 67 Ocrelizumab 66 Tocosol Paclitaxel 66 NATRECOR ® 66 Zavesca 66 oxypurinol 66 Vorapaxar 66 bicifadine 66 eltrombopag 66 Vernakalant 66 teriflunomide 66 Adentri 66 phase IIb trial 66 motavizumab 66 aldosterone antagonists 66 phase IIb clinical 66 CHAMPION PCI 66 ancrod 66 elotuzumab 66 HeFH 66 Zometa zoledronic acid 66 Nexavar sorafenib 66 cerebral vasospasm 65 ZOLINZA 65 ACTEMRA TM 65 cangrelor 65 recurrent glioblastoma multiforme 65 Lu AA# 65 candesartan cilexetil 65 TNF antagonist 65 motesanib 65 ximelagatran 65 Betaferon R 65 Eltrombopag 65 iniparib 65 Cancidas 65 refractory gout 65 Noxafil 65 salmeterol fluticasone 65 clevidipine 65 cediranib 65 HCV RESPOND 2 65 midstage clinical trial 65 Fibrillex 65 Candesartan 65 pill Exanta 65 phase IIIb 65 Arixtra 65 Recentin 65 Cerovive 65 eosinophilic asthma 65 telcagepant 65 Femara letrozole 65 vandetanib 65 morphometric vertebral fractures 65 Ambrisentan 65 Arranon 65 E2F Decoy 64 GOUT 64 Promacta 64 Oxypurinol 64 agomelatine 64 aclidinium 64 sorafenib Nexavar 64 NYHA Class II 64 chronic thromboembolic pulmonary 64 EXJADE 64 acute decompensated heart 64 phase III isavuconazole 64 ularitide 64 Bifeprunox 64 IOP lowering 64 Tolamba 64 Dasatinib 64 phase IIa 64 invasive aspergillosis 64 canakinumab 64 etanercept Enbrel 64 revascularizations 64 INCB# [003] 64 paricalcitol 64 Navelbine ® 64 AA Amyloidosis 64 Tasimelteon 64 interferon ribavirin 64 tocilizumab 64 Telintra 64 milrinone 64 TNF alpha inhibitor 64 rufinamide 64 rEV# 64 RSD# oral 64 Bicifadine 64 edifoligide 64 CYPHER Stent 64 paroxetine Paxil 64 ARCOXIA 64 alvimopan 64 phase IIb 64 idraparinux 64 Iressa lung cancer 64 thromboembolic complications 64 Nuvion 64 antiplatelet agent 64 posaconazole 64 adalimumab Humira 64 anagrelide 64 velafermin 64 LAF# 64 tolvaptan 64 gastrointestinal perforation 64 CytoFabTM 64 Fibrillex TM 64 severe hypercholesterolemia 64 Itopride 64 Alfimeprase 64 Febuxostat 64 Golimumab 64 lumiliximab 64 Safinamide 64 eculizumab therapy 63 DU #b 63 CTEPH 63 Hypotension 63 Darusentan 63 VIIBRYD 63 Rezular 63 efalizumab 63 Adalimumab 63 Natalizumab 63 Abilify aripiprazole 63 Gattex 63 ABSORB trial 63 trastuzumab DM1 63 IV NSCLC 63 PEGylated interferon beta 1a 63 nicardipine 63 prucalopride 63 Levetiracetam 63 Valdoxan 63 MS relapses 63 baminercept 63 Saxagliptin 63 Aflibercept 63 bezafibrate 63 CIMZIA ™ 63 eprotirome 63 brivaracetam 63 reslizumab 63 Romiplostim 63 Reminyl galantamine 63 SJIA 63 RhuDex 63 beta blocker therapy 63 Non inferiority 63 AGILECT R 63 dirucotide 63 cytopenias 63 enoximone 63 fluvastatin 63 Dacogen decitabine 63 MULTAQ 63 palifermin 63 Firazyr 63 BYSTOLIC 63 AEGR 63 Nesiritide 63 parecoxib 63 irbesartan 63 acute mania 63 Androxal TM 63 diarrhea predominant irritable 63 losartan Cozaar 63 efficacy endpoint 63 Kynapid 63 decompensated liver disease 63 levosimendan 63 TBC# 63 Acute Decompensated Heart Failure 63 Amrubicin 63 dual endothelin receptor antagonist 63 PROMACTA 63 systemic hypotension 63 INVEGA ® 63 Glypromate 63 Aceon 63 infliximab Remicade 63 MAGE A3 ASCI 63 Tolvaptan 63 pegaptanib 63 cinacalcet 63 Val HeFT 63 efaproxiral 63 investigational antiplatelet agent 63 hyperphenylalaninemia HPA due 63 GSK# [002] 63 sunitinib Sutent 63 glatiramer 63 reinfarction 63 Sutent sunitinib 63 Pivotal Phase III 63 randomized multicenter trial 63 Mipomersen 63 nadroparin 63 EMPHASIS HF trial 63 Dacogen injection 63 TASKi3 63 metastatic malignant 63 tafamidis 63 Motesanib 63 guanfacine extended release 62 refractory angina 62 Myelodysplastic Syndrome MDS 62 nalbuphine ER 62 Known hypersensitivity 62 mitoxantrone plus 62 REMINYL ® 62 esophageal candidiasis 62 MYDICAR 62 calcineurin inhibitor 62 Intravitreal 62 including eniluracil ADH 62 Relovair 62 Vidaza azacitidine 62 6R BH4 62 PRADAXA 62 oxymorphone ER 62 KRN# 62 Telcyta 62 bosutinib 62 Rebif ® 62 Arcalyst 62 #mg BID [001] 62 Paxil paroxetine 62 desvenlafaxine succinate 62 candesartan 62 CINQUIL 62 gastrointestinal stromal tumors GIST 62 cetuximab Erbitux R 62 Crestor rosuvastatin 62 BENICAR HCT 62 treprostinil 62 CYT# QbG# 62 immune thrombocytopenic purpura ITP 62 Ticagrelor 62 decompensated heart failure 62 ProSavin 62 Starlix 62 HBeAg negative patients 62 Pirfenidone 62 Prosaptide 62 intravenous cyclophosphamide 62 MERLIN TIMI 62 aldosterone antagonist 62 alfuzosin 62 recurrent DVT 62 gabapentin enacarbil 62 Ranolazine 62 DAPT 62 lomitapide 62 romiplostim 62 AVANDIA 62 zafirlukast 62 CYPHER R Sirolimus eluting 62 Novartis Diovan 62 Exanta 62 dopaminergic therapy 62 #mg dose [002] 62 Nebulized 62 bosentan 62 Subgroup analysis 62 ToGA 62 CIPN 62 pimecrolimus 62 investigational oral therapy 62 multicenter Phase II 62 HuMax EGFr 62 BoNTA 62 HuMax CD# 62 SinuNase 62 cardiotoxic 62 AERx 62 CANCIDAS 62 enoximone capsules 62 drug figitumumab 62 HIV HCV coinfected 62 Ereska 62 BARACLUDE ® 62 desmoteplase 62 oxaliplatin Eloxatin 62 TMP SMX 62 cetuximab Erbitux 62 TELINTRA 62 aripiprazole Abilify 62 antihypertensive therapy 62 levetiracetam Keppra 62 SinuNase TM 62 platelet inhibitor 62 recurrent VTE 62 Zybrestat 62 idiopathic pulmonary fibrosis IPF 62 relapsed MM 62 Cloretazine 62 INS# [001] 62 mycophenolic acid 62 sertraline Zoloft 62 bone marrow reticulin deposition 62 intermittent dosing 62 atherosclerotic renal artery stenosis 62 anticlotting drugs 62 Onbrez Breezhaler 62 Hydroxyurea 62 Avandia Actos 62 venous thromboembolic events 62 YONDELIS 62 darusentan 62 pantoprazole 62 hematological toxicity 62 senicapoc 62 Eli Lilly Cymbalta 62 Pyridorin 62 budesonide foam 62 fingolimod 62 panitumumab Vectibix 62 tanezumab 62 deferiprone 62 zibotentan 62 CTAP# Capsules 62 clodronate 62 QTc prolongation 62 Critical Limb Ischemia CLI 62 CDP# 62 active comparator 62 haematologic 62 IV tPA 62 phase IIb study 62 fondaparinux 62 angiographic outcomes 62 ULORIC 62 cilostazol 62 FOLFOX4 62 gepirone ER 62 docetaxel Taxotere ® 62 clomipramine 62 RSR# 62 hepatorenal syndrome 62 Pimavanserin 62 enalapril 62 Infusion Reactions Severe 62 ORENCIA ® 62 Xelox 62 antiarrhythmic 62 Decompensated Heart Failure 62 gefitinib Iressa 62 heparin induced thrombocytopenia 62 Acute Ischemic Stroke 62 everolimus eluting stents 62 Avanafil 62 Phase IIB 62 Seroquel quetiapine fumarate 62 divalproex sodium 62 Tocilizumab 62 biphasic insulin aspart 62 ELACYT 62 randomized Phase IIb 62 citalopram hydrobromide 62 drug Tracleer 62 dronedarone 61 hepatotoxicity 61 cannabinor 61 Retisert 61 Zavesca R 61 Pegloticase 61 Mycograb 61 cobiprostone 61 idiopathic thrombocytopenic purpura ITP 61 solanezumab 61 pomalidomide 61 Bondronat 61 Certolizumab pegol 61 Phenoptin 61 VFEND 61 Muraglitazar 61 Atrasentan 61 certolizumab 61 darapladib 61 almorexant 61 Advagraf 61 placebo controlled studies 61 genitourinary GU 61 stage IIIb IV 61 smoldering multiple myeloma 61 RLAI 61 Troxatyl 61 Rivaroxaban 61 non valvular atrial 61 hematologic toxicity 61 Asentar 61 olmesartan 61 Torisel 61 visilizumab 61 aprepitant 61 Factor Xa inhibitor 61 ticlopidine 61 xanthine oxidase inhibitor 61 maximal doses 61 QNEXA 61 ivabradine 61 rheumatoid arthritis psoriatic arthritis 61 apremilast 61 erlotinib Tarceva 61 leukotriene receptor antagonists 61 nephrotoxicity 61 tolevamer 61 figitumumab 61 opioid induced bowel dysfunction 61 dalteparin 61 adjuvant colon cancer 61 relapsed ALL 61 Zarnestra 61 Interferon beta 1b 61 midstage studies 61 ANCHOR trial 61 ibandronate 61 orally inhaled migraine 61 apixaban 61 factor Xa inhibitor 61 stable angina 61 pioglitazone HCl 61 non splenectomized 61 Inspra 61 Celebrex celecoxib 61 Iressa gefitinib 61 recurrent herpes labialis 61 oral methylnaltrexone 61 CLARITY study 61 albiglutide 61 Angioedema 61 GVAX 61 Tarceva TM 61 lupus nephritis 61 Trandolapril 61 antiarrhythmic drugs 61 Pazopanib 61 antithrombotic agents 61 Vitaxin 61 REMICADE ® 61 PEGINTRON TM 61 sargramostim 61 Aclidinium 61 relapsed CLL 61 PRIMO CABG 61 Tasigna nilotinib 61 tirofiban 61 taranabant 61 Actimmune ® 61 myelodysplastic myeloproliferative diseases 61 zotarolimus 61 risperidone Risperdal 61 KAPVAY ™ 61 pexelizumab 61 diabetic gastroparesis 61 parkinsonian symptoms 61 primidone 61 pamidronate 61 dose escalation phase 61 FTY# fingolimod 61 Genentech Rituxan 61 ribavirin therapy 61 Meets Primary Endpoint 61 PREZISTA r 61 acetonide FA 61 β blockers 61 BRIM3 61 placebo controlled clinical 61 antiarrhythmic drug 61 persistent pulmonary hypertension 61 BrachySil TM 61 nesiritide 61 Frovatriptan 61 bardoxolone methyl 61 Northera 61 Pulminiq 61 AVAPRO 61 Tekamlo 61 glufosfamide 61 MEVACOR 61 RE LY ® 61 tipranavir 61 retinal vein occlusion 61 overactive bladder syndrome 61 Solulin 61 sunitinib malate 61 FDA defined valvulopathy 61 corticosteroid dexamethasone 61 painful diabetic neuropathy 61 teduglutide 61 induce orthostatic hypotension 61 Aptivus ® 61 BRINAVESS 61 daclizumab 61 Pemetrexed 61 palonosetron 61 RELOVAIR ™ 61 pioglitazone hydrochloride 61 Lubiprostone 61 Erythropoietic therapies may 61 Keppra XR 61 retinal vein occlusion induced 61 aflibercept 61 homozygous familial hypercholesterolemia 61 cilengitide 61 Balaglitazone 61 PRISTIQ 61 ZACTIMA 61 UCB Cimzia 61 Aryplase 61 Luveris 61 Fabry Disease 61 Abrupt discontinuation 61 Losartan 61 PRT# 61 acute coronary syndromes ACS 61 thromboembolic events 61 axitinib 61 cytotoxic therapy 61 pertuzumab 61 PegIntron 61 CYT# potent vascular disrupting 61 vismodegib 61 AstraZeneca Iressa 61 symptomatic VTE 61 Decitabine 61 HCV SPRINT 61 streptokinase 61 glycated hemoglobin levels 61 Carvedilol 61 Betaferon ® 61 Phase IIIb study 61 recurrent GBM 61 cardiac repolarization 61 Intuniv 61 VAPRISOL 61 colorectal cancer liver metastases 61 eritoran 61 anti CD3 antibody 61 Onrigin 61 oral FTY# 61 IFN beta 61 Valsartan 61 GSK# [001] 61 neurologic progression 61 eplerenone 61 Doxil ® 61 ECASS 61 SNT MC# 61 Known generically 61 clopidogrel Plavix 61 hylan GF 61 oral Hycamtin 61 goserelin 61 ACZ# 61 Fablyn 61 zolmitriptan 61 iclaprim 61 Tykerb lapatinib 61 hyperkalemia 61 Ilaris 61 KETEK 61 nitrofurantoin 61 aneurysmal subarachnoid hemorrhage 61 AVERROES 61 Vicriviroc 61 avosentan 61 Provacel 61 edoxaban 61 RSV hospitalizations 61 Adenoma Prevention 61 methylnaltrexone 61 BRAF inhibitor 61 diabetic kidney 61 Vandetanib 61 nonrandomized 61 oral rivaroxaban 61 serum uric acid sUA 61 interferon beta therapy 61 Temsirolimus 61 severe exacerbations 60 mycophenolate mofetil 60 ralfinamide 60 candidemia 60 serum urate levels 60 forodesine 60 gadobutrol 60 Prilosec omeprazole 60 APTIVUS r 60 Zenapax 60 RSD# 60 ADVANCE PD 60 Roche Actemra 60 generalized edema 60 phase IIa clinical 60 Egrifta 60 venlafaxine XR 60 Instanyl 60 anthracycline taxane 60 Jevtana 60 beta 1a 60 TLK# 60 corifollitropin alfa 60 intravesical therapy 60 keloid scarring 60 lumiracoxib 60 Stent thrombosis 60 RoACTEMRA 60 Pivotal Phase 60 Octreolin 60 Sulonex 60 Pivotal Trial 60 superficial bladder cancer 60 ziconotide 60 selegiline 60 Alequel 60 BRIM2 60 Vfend 60 IV bisphosphonates 60 MoxDuo IR 60 gastrointestinal GI motility disorders 60 Bucindolol 60 DETROL LA 60 NAGS deficiency 60 Cellcept 60 oxcarbazepine 60 Plicera 60 rivaroxaban 60 hypercholesterolemic patients 60 Proellex TM 60 DULERA 60 FRAGMIN 60 Motavizumab 60 Liprotamase 60 tasocitinib 60 oxycodone CR 60 oral anticoagulant therapy 60 thromboprophylaxis 60 IL# PE#QQR 60 Major Depressive Disorder 60 failure ADHF 60 thienopyridines 60 desvenlafaxine 60 Certican 60 Brilique 60 micafungin 60 detemir 60 venlafaxine Effexor 60 herpetic keratitis 60 artery stenosis 60 heterozygous FH 60 ABC/3TC 60 postoperative ileus 60 VA# [002] 60 opioid induced 60 Pagoclone 60 ACE Inhibitors 60 Targretin 60 Aplidin 60 steroid refractory ulcerative 60 alemtuzumab treated 60 zalutumumab 60 antidiabetic drug 60 ruxolitinib 60 mertansine 60 Cimzia TM 60 Vectibix panitumumab 60 Serdolect ® 60 Liraglutide 60 #mg QD [001] 60 ASA# 60 Serdolect 60 orBec 60 A1PI 60 Arikace 60 Monopril 60 anti arrhythmic drug 60 oral mTOR inhibitor 60 receptor inhibitor 60 #mg dosing 60 Cipralex ® 60 noninfectious uveitis 60 Paraplatin 60 Oglemilast 60 mixed hyperlipidemia 60 vidofludimus 60 ULTRAM ER 60 Adcirca 60 TNF Tumor Necrosis Factor 60 Ivabradine 60 EDARBI 60 Zoloft sertraline 60 benign prostatic hypertrophy BPH 60 ß blockers 60 pan HDAC inhibitor 60 ARB telmisartan 60 Bosentan 60 lamotrigine 60 constipation predominant irritable bowel 60 Azacitidine 60 carvedilol 60 fenretinide 60 Fondaparinux 60 sJIA 60 nondiabetic patients 60 midstage trials 60 olanzapine LAI 60 Alemtuzumab 60 proliferative retinopathy 60 CIMZIA TM 60 VTE prophylaxis 60 achieved ACR# 60 somatostatin analog 60 comparator arm 60 Torsades de Pointes 60 Aprotinin 60 pain palliation 60 ReoPro 60 tegaserod 60 ASCEND HF 60 #mg/day [001] 60 Factor VIIa 60 postoperative ileus POI 60 rhThrombin 60 aspirin clopidogrel 60 carcinoid syndrome 60 Oral corticosteroids 60 Aviptadil 60 active ankylosing spondylitis 60 acutely decompensated heart 60 Denufosol 60 either acutely decompensated 60 icatibant 60 trastuzumab Herceptin ® 60 Microplasmin 60 ACTOS ® 60 galantamine 60 Toremifene 60 lumbar spinal stenosis LSS 60 Zyprexa olanzapine 60 Neupro R 60 Helicobacter pylori eradication 60 Lantus insulin 60 arterial thrombosis 60 mRCC 60 HuMax CD4 60 INSPIRE Trial Phase III 60 Elocalcitol 60 systolic dysfunction 60 neurogenic orthostatic hypotension 60 ritonavir boosted 60 antiepileptic drug 60 octreotide LAR 60 pregabalin Lyrica 60 liver transplant recipients 60 RE LY 60 recurrent venous thromboembolism 60 chronic idiopathic thrombocytopenic purpura 60 BENICAR 60 PRIMO CABG2 60 Ropinirole 60 INTEGRILIN R 60 Randomized Phase 60 PLX STROKE targeting 60 PICSO ® 60 Forodesine HCl 60 NEVO 60 metastatic malignant melanoma 60 cerebral ischemia 60 bovine thrombin 60 rosuvastatin #mg 60 reduce serum phosphate 60 EVIZON TM 60 amisulpride 60 HBeAg positive patients 60 valdecoxib 60 rosuvastatin Crestor 60 thrombocytopenic 60 Raptiva R 60 antithrombotic agent 60 Fibrin Pad 60 tramiprosate 60 cardiotoxicity 60 BAY #-# 60 Oral Fingolimod 60 TMC# r 60 Serious adverse reactions 60 β blocker 60 unstable angina pectoris 60 Trovax 60 tesofensine 60 intravenous methylnaltrexone 60 azilsartan medoxomil 60 tranylcypromine 60 antithrombotic therapy 60 cardio renal 60 Rasilez Tekturna 60 malignant ascites 60 NSABP C 60 Olmesartan 60 VEGF inhibitors 60 hepatic encephalopathy 60 Ischemic 60 Ixempra 60 Gaboxadol 60 PTK ZK 60 Tracleer R 60 Renal Cell Carcinoma RCC 60 Abbokinase 60 GAMMAGARD 60 RhuDex ® 60 cerebrovascular events 60 Cardiotoxicity 60 ACUITY trial 60 antiangiogenic therapy 60 Eculizumab 60 dyslipidaemia 60 thromboembolic disease 60 lurasidone 60 coxib 60 PNH patients 60 benazepril 60 adjunctive placebo 60 heparins 60 biliary tract cancer 60 glitazones 60 novel VDA molecule 60 Sutent sunitinib malate 60 deep venous thromboses 60 Lupuzor 60 mild renal insufficiency 60 noninferior 60 ARCALYST ® 60 sorafenib tablets 60 Roche Xeloda 60 pulmonary arterial hypertension PAH 60 rasagiline tablets 60 Phase #/#a 60 Randomized Double blind 60 PREOS 60 Nexium esomeprazole 60 refractory CLL 60 Hedgehog Pathway Inhibitor 60 ImClone Erbitux 60 inhibitor RG# 60 multicenter placebo controlled 60 Hematologic 60 PRADAXA #mg 60 humanised monoclonal antibody 60 Pfizer Sutent 60 brimonidine 60 venous stasis ulcers 60 reboxetine 60 Dabigatran 60 thalidomide Thalomid 60 flutamide 60 virologic failure 60 anticoagulant warfarin 60 glomerular filtration 60 Hepatocellular Carcinoma HCC 60 unfractionated heparin UFH 60 interferon beta 1b 60 intravenous iv 60 elacytarabine 60 CytoFab ™ 60 renal flares 60 Excellarate TM 60 Tarceva erlotinib 60 DPP4 60 fostamatinib 60 Neupro patch 60 angioedema 60 interferon gamma 1b 60 rimonabant #mg 60 arzoxifene 60 Velcade bortezomib 60 phase Ib 60 direct thrombin inhibitors 60 TNF inhibitor 60 Phase IIa trial 60 baseline HbA1c 60 PSN# [002] 60 aflibercept VEGF Trap 60 canagliflozin 60 Syncria 60 pulmonary arterial hypertension 60 glycoprotein IIb IIIa inhibitor 60 Benign Prostatic Hyperplasia 60 otamixaban 60 MIRAPEX ER 60 AGHD 60 VIAject 60 levocetirizine 60 postmenopausal osteoporotic women 60 thromboembolic 60 SCIg 60 NeuroVax 60 Phase IIb clinical trials 60 Ophena 60 retransplantation 60 medically refractory 60 clobazam 60 ischemic cardiomyopathy 60 interstitial pneumonia 60 Danazol 60 Zytiga 60 rilonacept 60 Teriparatide 60 Effexor venlafaxine 60 OvaRex 60 neutropenia dehydration dyspnea 60 postoperative mortality 60 randomized multicenter Phase III 60 sodium thiosulfate STS 60 XZK 60 Ceflatonin 60 dose cohort 60 flecainide 60 vildagliptin 60 drug eluting stent implantation 60 catheter occlusion 60 saphenous vein graft 60 FOLOTYN ® 60 thrombotic complications 60 headache nasopharyngitis 60 nimodipine 60 ticagrelor 60 Perforomist Inhalation Solution 60 Darapladib 59 allogeneic HSCT 59 dexpramipexole 59 Sprycel dasatinib 59 COREG CR 59 mepolizumab 59 ARIXTRA 59 mecamylamine 59 intravitreal insert 59 standard chemotherapy regimen 59 RISPERDAL ® 59 SIMPADICO trial 59 Arxxant 59 muraglitazar 59 multicenter randomized placebo controlled 59 oral antidiabetes 59 refractory NSCLC 59 Dapagliflozin 59 relapsed ovarian cancer 59 Ozurdex 59 Tipranavir 59 BZA CE 59 octreotide acetate 59 dosing frequency 59 mcg QD 59 antidepressants fluoxetine 59 NEVO ™ 59 hemodynamic instability 59 Phase IIIb clinical 59 efficacy tolerability 59 glitazone 59 EFAPROXYN 59 delivers fluocinolone acetonide FA 59 MIRAPEX 59 headache abdominal pain 59 briakinumab 59 eszopiclone 59 APPRAISE 59 alkylating agent 59 nadolol 59 incyclinide